Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02625623
Title Avelumab in Third-Line Gastric Cancer (JAVELIN Gastric 300)
Recruitment Completed
Gender both
Phase Phase III
Variant Requirements No
Sponsors EMD Serono
Indications
Therapies
Age Groups: adult
Covered Countries USA | ITA | FRA | ESP | DEU | BEL | AUS


No variant requirements are available.